Orphan designation: adeno-associated virus vector serotype SAN011 encoding a microRNA against DMPK mRNA Treatment of dystrophic myotonia type 1, 11/10/2024 Positive

Orphan designation: adeno-associated virus vector serotype SAN011 encoding a microRNA against DMPK mRNA Treatment of dystrophic myotonia type 1, 11/10/2024 Positive

Informative webinar on PMS Product User Interface usage and key actions for Marketing Authorisation Holders (with demo), Online, Amsterdam, the Netherlands, from 29 October 2024, 10:00 (CET) to 29 October 2024, 12:00 (CET)

Informative webinar on PMS Product User Interface usage and key actions for Marketing Authorisation Holders (with demo), Online, Amsterdam, the Netherlands, from 29 October 2024, 10:00 (CET) to 29 October 2024, 12:00 (CET)

Human medicines European public assessment report (EPAR): Ogivri, trastuzumab, Date of authorisation: 12/12/2018, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Ogivri, trastuzumab, Date of authorisation: 12/12/2018, Revision: 12, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.